Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
Background & Aims. Endometrial tubal metaplasia (ETM) is mostly described in conjunction with unopposed estrogen levels, and its association with endometrial hyperplasia and endometrial carcinoma (EC) is striking. Obesity is a risk factor for endometrial hyperplasia and EC development. The aim o...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Obesity |
Online Access: | http://dx.doi.org/10.1155/2020/2825905 |
id |
doaj-edb82a7988b845879e68ec7ce7b93962 |
---|---|
record_format |
Article |
spelling |
doaj-edb82a7988b845879e68ec7ce7b939622020-11-25T02:59:32ZengHindawi LimitedJournal of Obesity2090-07082090-07162020-01-01202010.1155/2020/28259052825905Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?Ayman M. El-Saka0Yomna A. Zamzam1Yosra A. Zamzam2Ayman El-Dorf3Department of Pathology, Faculty of Medicine, Tanta University, Tanta, EgyptDepartment of Pathology, Faculty of Medicine, Tanta University, Tanta, EgyptDepartment of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, EgyptDepartment of Gynecology and Obstetrics, Faculty of Medicine, Tanta University, Tanta, EgyptBackground & Aims. Endometrial tubal metaplasia (ETM) is mostly described in conjunction with unopposed estrogen levels, and its association with endometrial hyperplasia and endometrial carcinoma (EC) is striking. Obesity is a risk factor for endometrial hyperplasia and EC development. The aim of this study is to investigate the impact of BMI and serum estradiol level on expression of PAX-2, H-TERT, P16, Ki-67, and P53 in studied ETM in reference to benign endometrium and EC. Methods. The study was conducted on the following groups: group (1) consists of 57 cases that had endometrial biopsies with histologically demonstrable ETM (typical or atypical) and all were subjected to serum estradiol levelling and body mass index (BMI) evaluation; group (2) had adjacent benign endometrial tissue as control; group (3) consists of 52 cases of conventional endometrial carcinoma and 16 serous carcinoma paraffin blocks which were collected and reevaluated. All included groups were immunostained for PAX-2, H-TERT, p16, ki67, and p53. Results. The relation between BMI and serum estradiol level in group 1 and PAX-2, H-TERT, P16, and p53 was statistically significant, while their relation with atypia and ki67 expression was insignificant. Twenty-three ETM cases (40.4%) out of group 1 were all (100%) obese, 87% had high serum estradiol level, and 73.9% were postmenopausal and had a similar immunohistochemical profile as EC cases (group 3). Conclusions. The presence of ETM regardless of the histologic atypia in obese postmenopausal patients with high serum estradiol level is an alarming sign. This implies that ETM might not be as benign as generally accepted, as under certain clinical conditions, it may turn into a potential premalignant lesion.http://dx.doi.org/10.1155/2020/2825905 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ayman M. El-Saka Yomna A. Zamzam Yosra A. Zamzam Ayman El-Dorf |
spellingShingle |
Ayman M. El-Saka Yomna A. Zamzam Yosra A. Zamzam Ayman El-Dorf Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion? Journal of Obesity |
author_facet |
Ayman M. El-Saka Yomna A. Zamzam Yosra A. Zamzam Ayman El-Dorf |
author_sort |
Ayman M. El-Saka |
title |
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion? |
title_short |
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion? |
title_full |
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion? |
title_fullStr |
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion? |
title_full_unstemmed |
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion? |
title_sort |
could obesity be a triggering factor for endometrial tubal metaplasia to be a precancerous lesion? |
publisher |
Hindawi Limited |
series |
Journal of Obesity |
issn |
2090-0708 2090-0716 |
publishDate |
2020-01-01 |
description |
Background & Aims. Endometrial tubal metaplasia (ETM) is mostly described in conjunction with unopposed estrogen levels, and its association with endometrial hyperplasia and endometrial carcinoma (EC) is striking. Obesity is a risk factor for endometrial hyperplasia and EC development. The aim of this study is to investigate the impact of BMI and serum estradiol level on expression of PAX-2, H-TERT, P16, Ki-67, and P53 in studied ETM in reference to benign endometrium and EC. Methods. The study was conducted on the following groups: group (1) consists of 57 cases that had endometrial biopsies with histologically demonstrable ETM (typical or atypical) and all were subjected to serum estradiol levelling and body mass index (BMI) evaluation; group (2) had adjacent benign endometrial tissue as control; group (3) consists of 52 cases of conventional endometrial carcinoma and 16 serous carcinoma paraffin blocks which were collected and reevaluated. All included groups were immunostained for PAX-2, H-TERT, p16, ki67, and p53. Results. The relation between BMI and serum estradiol level in group 1 and PAX-2, H-TERT, P16, and p53 was statistically significant, while their relation with atypia and ki67 expression was insignificant. Twenty-three ETM cases (40.4%) out of group 1 were all (100%) obese, 87% had high serum estradiol level, and 73.9% were postmenopausal and had a similar immunohistochemical profile as EC cases (group 3). Conclusions. The presence of ETM regardless of the histologic atypia in obese postmenopausal patients with high serum estradiol level is an alarming sign. This implies that ETM might not be as benign as generally accepted, as under certain clinical conditions, it may turn into a potential premalignant lesion. |
url |
http://dx.doi.org/10.1155/2020/2825905 |
work_keys_str_mv |
AT aymanmelsaka couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion AT yomnaazamzam couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion AT yosraazamzam couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion AT aymaneldorf couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion |
_version_ |
1715334093019807744 |